References
- 1
Dumot J A, Vargo J J, Falk G W et al.
An open-label, prospective trial of cryospray ablation of Barrett's esophagus high-grade
dysplasia and early esophageal cancer in high-risk patients.
Gastrointest Endosc.
2009;
70
635-644
- 2
Greenwald B D, Dumot J A, Horwhat J D et al.
Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray
cryotherapy in the esophagus.
Dis Esophagus.
2009;
23
13-19
- 3
Ganz R A, Overholt B F, Sharma V K et al.
Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia:
a U.S. multicenter registry.
Gastrointest Endosc.
2008;
68
35-40
- 4
Greenwald B D, Dumot J A, Abrams J A et al.
Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy.
Gastrointest Endosc.
2010;
71
686-693
- 5
Shaheen N J, Greenwald B D, Peery A F et al.
Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade
dysplasia.
Gastrointest Endosc.
2010;
71
680-685
- 6
Xue H B, Tan H H, Liu W Z et al.
A pilot study of endoscopic spray cryotherapy by pressurized carbon dioxide gas for
Barrett's esophagus.
Endoscopy.
2011;
43
- 7
Pasricha P J, Hill S, Wadwa K S et al.
Endoscopic cryotherapy: experimental results and first clinical use.
Gastrointest Endosc.
1999;
49
627-631
B. D. GreenwaldMD
University of Maryland School of Medicine and Greenebaum Cancer Center
22 South Greene Street
N3W62 Baltimore
MD 21201–1595
USA
Fax: +1-410-328-8315
Email: Bgreenwa@medicine.umaryland.edu
